Showing results (1621-1630 of 2,449) with videos related to
Sort By:
Pageof 245
Clinical and Translational Science|February 11, 2025
Once-Weekly Semaglutide Versus Once-Daily Liraglutide for Weight Loss in Adults: A Meta-Analysis of Randomized Controlled TrialsTallal Mushtaq Hashmi, Mushood Ahmed, Ali Haider, et al.Clinical and Translational Science|January 21, 2025
Establishment and Validation of a Machine-Learning Prediction Nomogram Based on Lymphocyte Subtyping for Intra-Abdominal Candidiasis in Septic PatientsJiahui Zhang, Wei Cheng, Dongkai Li, et al.Clinical and Translational Science|January 17, 2025
CYP2C19 Genotype-Guided Antiplatelet Therapy and Clinical Outcomes in Patients Undergoing a Neurointerventional ProcedureKayla R Tunehag, Ashton F Pearce, Layna P Fox, et al.Clinical and Translational Science|November 13, 2024
Concentration-QTcF analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemiaPavan Vaddady, Giovanni Smania, Shintaro Nakayama, et al.Clinical and Translational Science|November 5, 2024
Clinical pharmacokinetics and pharmacodynamics of ongericimab: A potential long-acting PCSK9 monoclonal antibody in healthy subjects and patients with hypercholesterolemia: Randomized, double-blind, placebo-controlled phase Ia and Ib/II studiesJuanjuan Jiang, Li Xu, Lin Chai, et al.Clinical and Translational Science|November 11, 2024
The needs and gaps in pharmacogenomics knowledge and education among healthcare professionals in Malaysia: A multisite Delphi studySafa Omran, Siew Lian Leong, Ali Blebil, et al.Clinical and Translational Science|November 8, 2024
Comparing machine learning and deep learning models to predict cognition progression in Parkinson's diseaseEdgar A Bernal, Shu Yang, Konnor Herbst, et al.Clinical and Translational Science|November 29, 2024
Pharmacogenetic-guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFIC-PGx): A multicenter clinical trialSarah Glewis, Senthil Lingaratnam, Benjamin Lee, et al.Clinical and Translational Science|November 28, 2024
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral allosteric TYK2 inhibitor ESK-001 using a randomized, double-blind, placebo-controlled study designSibel Ucpinar, Joyce K Kwan, Joshua D Hoffman, et al.Clinical and Translational Science|November 27, 2024
Trends of in vitro pharmacological potency and in vivo pharmacokinetics parameters of modern drugs: Can the therapeutic/subtherapeutic dose be estimated from in vitro Ki and pharmacokinetic parameters?Toshiaki Tsuchitani, Motohiro Kato, Atsuko Tomaru, et al.Pageof 245